Results 181 to 190 of about 6,977 (282)

Shear Thickening, Star-Shaped Polymer Electrolytes for Lithium-Ion Batteries. [PDF]

open access: yesMolecules
Słojewska M   +3 more
europepmc   +1 more source

Role of extracellular carbonic anhydrase in the polar diatom Fragilariopsis cylindrus

open access: yesNew Phytologist, EarlyView.
Summary Diatoms are major primary producers in productive polar oceans, where cold temperatures and high CO2 solubility raise questions as to whether they rely on the CO2‐concentrating mechanism (CCM) to saturate photosynthesis. Knowledge of CCM function will help better predict the sensitivity of diatom primary production to warming and acidifying ...
Meng Li, Jodi N. Young
wiley   +1 more source

Ozonized Hydrogel and Chlorhexidine Gel for Peri‐Implant Mucositis: A 24‐Month Randomized Controlled Trial

open access: yesOral Diseases, EarlyView.
ABSTRACT Objective This randomized controlled trial evaluated the 24‐month effectiveness of a nonsurgical intervention for peri‐implant mucositis, comparing a 15% ozonated sunflower oil hydrogel with a 1% chlorhexidine gel. Methods Thirty patients with 360 peri‐implant mucositis sites were treated in a split‐mouth design, receiving both therapies in ...
Andrea Scribante   +5 more
wiley   +1 more source

Approach to lubricant use for sexual activity. [PDF]

open access: yesCan Fam Physician
Vanderschee R, Kostov S.
europepmc   +1 more source

Prevention of Atopic Dermatitis in High‐Risk Infants: A Review of the Role of Lipid‐Based Barrier Repair Therapy

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Background/Objective Growing evidence highlights the role of physiological lipids, namely ceramides, cholesterol, and free fatty acids, in maintaining skin barrier function and preventing atopic dermatitis (AD). Current evidence on the efficacy, safety, and clinical relevance of stratum corneum (SC) lipid‐based therapies to prevent AD and ...
Chon‐Wai Jeremy Chan   +1 more
wiley   +1 more source

Long‐Term Safety and Efficacy of Once‐Daily and Proactive Twice‐Weekly Roflumilast Cream 0.05% for Mild‐to‐Moderate Atopic Dermatitis in Children Aged 2–5 Years From a 52‐Week, Phase 3 Trial (INTEGUMENT‐OLE)

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Background INTEGUMENT‐PED/NCT04845620, a 4‐week, phase 3 trial, demonstrated efficacy and safety of roflumilast cream 0.05% in children aged 2–5 years with mild‐to‐moderate atopic dermatitis (AD). A phase 3 open‐label extension trial (INTEGUMENT‐OLE [NCT04804605]) investigated long‐term outcomes continuing roflumilast cream for ≤ 56 weeks ...
Lawrence F. Eichenfield   +14 more
wiley   +1 more source

Use of lorazepam for analgosedation during mechanical ventilation in pediatric intensive care. [PDF]

open access: yesFront Med (Lausanne)
Healy P   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy